-
Feb 25, 2020, 10:09 AM
by
Michael Croft
HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Banks intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roches PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors
Full story
-
Feb 25, 2020, 09:15 AM
by
Michael Croft
BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)
Full story
-
Feb 25, 2020, 08:36 AM
by
Michael Croft
PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
Full story
-
Feb 25, 2020, 04:50 AM
by
Michael Croft
CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies
Full story
-
Feb 24, 2020, 10:20 AM
by
Michael Croft
LA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco
Full story
-
Feb 24, 2020, 09:32 AM
by
Michael Croft
CAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community
Full story
-
Feb 24, 2020, 05:19 AM
by
Michael Croft
GLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor device
Full story
-
Feb 24, 2020, 05:13 AM
by
Michael Croft
DUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globally
Full story
-
Feb 24, 2020, 03:31 AM
by
Michael Croft
SHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researches
Full story
-
Feb 21, 2020, 18:05 PM
by
Michael Croft
Bio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.
Full story
-
Feb 20, 2020, 21:48 PM
by
Michael Croft
SHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industry
Full story
-
Feb 20, 2020, 10:30 AM
by
Michael Croft
Bio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).
Full story
-
Feb 20, 2020, 09:40 AM
by
Michael Croft
REDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms
Full story
-
Feb 19, 2020, 15:20 PM
by
Michael Croft
Bio-IT World | Some big investments are driving CRISPR-based therapeutics, cell therapies, sepsis diagnostics and more this year. Unspecified investments by pharma are further propelling Seqster’s health data management platform.
Full story
-
Feb 19, 2020, 13:30 PM
by
Michael Croft
NEEDHAM, MA, UNITED STATES - Feb 19, 2020 - Bio-IT World 2020, the premier conference and expo uniting life science, data science, informatics and IT leaders, today announced its Plenary Keynote sessions
Full story
-
Feb 18, 2020, 23:09 PM
by
Michael Croft
SHIRLEY, NY, USE - Feb 19, 2020 - February 19, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody field, announced that the nimotuzumab, a kind of anti-EGFR therapeutic antibody, is now available for research and clinical use
Full story
-
Feb 18, 2020, 09:03 AM
by
Michael Croft
ORLANDO, FL, UNITED STATES - Feb 18, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trials
Full story
-
Feb 18, 2020, 08:57 AM
by
Michael Croft
PHILADELPHIA - Feb 18, 2020 - Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office facility in Blue Bell, Pennsylvania
Full story
-
Feb 18, 2020, 08:50 AM
by
Michael Croft
CAMBRIDGE, UNITED KINGDOM - Feb 18, 2020 - Optibrium, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development
Full story
-
Feb 17, 2020, 15:00 PM
by
Michael Croft
Bio-IT World Bioinformatics.org today announced the finalists in the 2020 Benjamin Franklin Award for Open Access in the Life Sciences. Voting is open to Bioinformatics.org members, and will be open until Friday, February 28. The winner will be announced at the 2020 Bio-IT World Conference & Expo.
Full story